LLY241115C690000
- 99.90
- 0.000.00%
Eli Lilly and Co Newsroom
Express News | eli lilly and co: The weight loss drug Tirzepatide achieved all major endpoints in Phase III clinical trials.
Express News | Lilly's Tirzepatide Reduced the Risk of Worsening Heart Failure Events by 38% in Adults With Heart Failure With Preserved Ejection Fraction (Hfpef) and Obesity
Shareholders Should Be Pleased With Eli Lilly and Company's (NYSE:LLY) Price
Trading Volume TOP20 | "AI Bull Stock" palantir soared more than 11%! Announced the transfer to nasdaq for listing; Cryptos concept stocks generally rose, Coinbase up nearly 10%
On Friday, Tesla, the top trading volume in the U.S. stock market, closed up 3.07%, with a turnover of 36.387 billion U.S. dollars. Nvidia, ranked second, fell by 3.26%, with a turnover of 35.606 billion U.S. dollars.
Large Pharmas, Biotechs Down as Industries Grapple With RFK Jr. at HHS
U.S. Pharma Is Largely Immune From 'MAHA' Impact: Wolfe
Trending Stocks Today | The Arena Group Surges 182.45%
November 15th - US stocks trending in regular trading hours.Gainers: $The Arena Group(AREN.US)$ surges 182.45% to $1.61 with a turnover of $151.46 million. $CERo Therapeutics(CERO.US)$ soars 58.17%
Powell Speaks The Truth - Market Does Not Like It, Consternation About Kennedy, Gaetz, And Hegseth
Shares of Pharmaceutical Companies Are Trading Lower After President-elect Trump Nominated Robert F. Kennedy Jr. to Lead the HHS.
RFK Jr. Is Not a Fan of Weight-loss Drugs or Vaccines. Stocks Are Tanking.
Express News | Biotechnology etf plunges! Pharmaceutical stocks collectively decline, with the United States Secretary of Health and Human Services nominee raising market concerns.
Least Shorted S&P 500 Stocks in October
Eli Lilly and Co (LLY.US) and Johnson & Johnson (JNJ.US) have successively sued American institutions for obstructing pharmaceutical discount plans.
Eli Lilly and Co has filed a lawsuit against the United States Health Resources and Services Administration, accusing them of unreasonably trying to block Eli Lilly's specific discounting scheme for drugs supplied under the government's 340B program.
Heard on the Street: RFK Jr. Is Spooking Obesity Investors Too -- WSJ
Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030
Top private equity funds in China expose the 'US stock report': the proportion of Chinese concept stocks continues to rise, with PDD Holdings and Apple being the focus of differences in components.
In the third quarter of this year, most Chinese private equity firms, such as Hillhouse, Gao Yi, and Jinglin, remained focused on Chinese concept stocks. However, Hillhouse and Jinglin chose to reduce their shareholding in pdd holdings, while Gao Yi opted to continue increasing its stake in pdd holdings.
Morgan Stanley's Q3 holdings in U.S. stocks have been released: Microsoft firmly holds the top position among major holdings, while popular ai chip stocks like AMD have seen shareholding reductions.
According to the disclosure of the Securities and Exchange Commission (SEC) in the USA, Wall Street financial giant JPMorgan has submitted the Form 13F of US stock holdings for the third quarter ending on September 30, 2024.
Eli Lilly Sues US Health Resources Administration Over Drug Discount Payment Process
Wolfe Research Initiates Coverage On Eli Lilly With Outperform Rating, Announces Price Target of $1000
Eli Lilly Analyst Ratings